Lanean...
Use of Tocilizumab in Management of Post-Operative Myelomonocytic Leukemoid Reaction
Interleukin 6 receptor (IL6R) inhibitor, tocilizumab, has been effectively used in the treatment of cytokine release syndrome in patients receiving chimeric antigen receptor T-cell therapy. Here we present a patient with chronic myelomonocytic leukemia (CMML) who developed a steroid refractory, post...
Gorde:
| Argitaratua izan da: | Leuk Res Rep |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7672312/ https://ncbi.nlm.nih.gov/pubmed/33240789 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2020.100228 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|